Bortezomib-based antibody depletion for refractory autoimmune hematological diseases.
Ratnasingam S, Walker PA, Tran H, Kaplan ZS, McFadyen JD, Tran H, Teh TC, Fleming S, Catalano JV, Chunilal SD, Johnston A, Opat SS, Shortt J.
Ratnasingam S, et al. Among authors: kaplan zs.
Blood Adv. 2016 Nov 22;1(1):31-35. doi: 10.1182/bloodadvances.2016001412. eCollection 2016 Nov 29.
Blood Adv. 2016.
PMID: 29296693
Free PMC article.